Menu

ePharmacy is the new buzz word in the market with global giant Amazon and home-grown conglomerate Reliance Industries Limited making launches and acquisitions in less than a week.

In India, COVID-19 was the biggest driver for ePharmacy. Nineteen state governments declared ePharmacy as an essential service during the lockdown.

ePharmacy solutions are ideal for cash pay markets like India. Data from published sources like FICCI show that ePharmacy has made inroads into about 9 million households in the country, largely driven by the lockdown. Before COVID-19, about 3.5 million families were using ePharmacy services.

The ePharmacy space in India is currently in the consolidation phase. The M&A spree started in 2019 with Medlife acquiring Myra, before the recent developments, including, Reliance acquiring Netmeds, and Pharmeasy merging with Medlife. This is just the beginning with many more mergers, acquisitions, and investments likely to happen in the next few quarters. Amazon Pharmacy’s expansion strategy in India will be something to watch. It is important to note that Amazon made PillPack synonymous with online pharmacy in the US within two years. In the US, Amazon Pharmacy targets chronic disease patients and delivers medicines to their doorstep, which has also increased medication adherence in the country.

The ePharmacy market is likely to expand and integrate online consultation, online lab testing, and doctor consultations, including scheduling, claims management, etc. This will open up Pandora’s Box for data security and patient safety; however, with the proper regulatory framework, guidelines, regular inspections, and interventions, this market is going to boom.

By 2025, Frost & Sullivan expects ePharmacy to penetrate 70 million households in India and for the ePharmacy market to grow to 75+ companies.

About Sowmya Srinath

Sowmya SrinathSowmya Srinath is the Director of Frost & Sullivan's Transformational Health team for the South Asia region. She has over a decade of industry experience in consulting and advisory services and research recommendations. Her expertise lies in the medical device sector, with a special focus on market research in cardiology, orthopedic, and wound care sector.

Sowmya SrinathSowmya Srinath

Sowmya Srinath is the Director of Frost & Sullivan's Transformational Health team for the South Asia region. She has over a decade of industry experience in consulting and advisory services and research recommendations. Her expertise lies in the medical device sector, with a special focus on market research in cardiology, orthopedic, and wound care sector.

Akshay ZanjurneAkshay Zanjurne

Akshay Zanjurne is the Program Manager with Frost & Sullivan's Transformational Health team for the Middle East and South Asia region. He has more than four years of industry experience in consulting and research recommendations. His expertise lies in the Pharmaceuticals, Biotechnology & Drug Discovery Technologies sector.

Have Questions?

We have Answers.

Schedule a Complimentary Growth Strategy
Dialogue with an Industry Expert

Call Frost & Sullivan Icon

877.GoFrost

(877.463.7678)

Email Frost & Sullivan

myfrost@frost.com

Frost & Sullivan Footer Logo

Powering Clients to a Future Shaped by Growth

Frost & Sullivan Twitter    Frost & Sullivan LinkedIn

Subscribe to the Growth Opportunity Newsletter!

Share This
X